WELL Health Technologies (TSE:WELL) Stock Price Expected to Rise, CIBC Analyst Says

WELL Health Technologies (TSE:WELL) had its price objective raised by analysts at CIBC from C$5.00 to C$5.25 in a research report issued on Friday,BayStreet.CA reports. CIBC’s price target would indicate a potential downside of 1.69% from the stock’s current price.

Separately, Ventum Financial cut their price objective on WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating for the company in a report on Tuesday, October 29th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, WELL Health Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of C$7.00.

WELL Health Technologies Stock Up 8.3 %

Shares of WELL Health Technologies stock opened at C$5.34 on Friday. WELL Health Technologies has a 1-year low of C$3.41 and a 1-year high of C$5.38. The business’s fifty day moving average price is C$4.45 and its two-hundred day moving average price is C$4.33. The company has a debt-to-equity ratio of 41.57, a current ratio of 1.25 and a quick ratio of 1.02. The company has a market capitalization of C$1.33 billion, a P/E ratio of 9.37, a PEG ratio of -1.93 and a beta of 1.20.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.